These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 26267323)

  • 1. Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells.
    Ge F; Zhang H; Wang DD; Li L; Lin PP
    Oncotarget; 2015 Sep; 6(29):27049-64. PubMed ID: 26267323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated EpCAM-independent subtraction enrichment and iFISH strategies to detect and classify disseminated and circulating tumors cells.
    Lin PP
    Clin Transl Med; 2015 Dec; 4(1):38. PubMed ID: 26718583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive characterization of chemotherapeutic efficacy on metastases in the established gastric neuroendocrine cancer patient derived xenograft model.
    Jiang J; Wang DD; Yang M; Chen D; Pang L; Guo S; Cai J; Wery JP; Li L; Li HQ; Lin PP
    Oncotarget; 2015 Jun; 6(17):15639-51. PubMed ID: 25909226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive in situ co-detection of aneuploid circulating endothelial and tumor cells.
    Lin PP; Gires O; Wang DD; Li L; Wang H
    Sci Rep; 2017 Aug; 7(1):9789. PubMed ID: 28852197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting and phenotyping of aneuploid circulating tumor cells in patients with various malignancies.
    Ye Z; Ding Y; Chen Z; Li Z; Ma S; Xu Z; Cheng L; Wang X; Zhang X; Ding N; Zhang Q; Qian Q
    Cancer Biol Ther; 2019; 20(4):546-551. PubMed ID: 30572767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantified postsurgical small cell size CTCs and EpCAM
    Wang L; Li Y; Xu J; Zhang A; Wang X; Tang R; Zhang X; Yin H; Liu M; Wang DD; Lin PP; Shen L; Dong J
    Cancer Lett; 2018 Jan; 412():99-107. PubMed ID: 29031565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.
    Deng G; Herrler M; Burgess D; Manna E; Krag D; Burke JF
    Breast Cancer Res; 2008; 10(4):R69. PubMed ID: 18687126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of phenotyping and karyotyping of detecting circulating tumor cells in renal cell carcinoma using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH).
    Tian D; Zhang M; Zheng G; Zhang Y; Li Y; Lin P; Li H; Jiao W; Niu H
    Int Urol Nephrol; 2020 Dec; 52(12):2281-2287. PubMed ID: 32748196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of phenotyping and karyotyping of circulating tumor cells in patients with advanced gastric cancer.
    Li Y; Zhang X; Ge S; Gao J; Gong J; Lu M; Zhang Q; Cao Y; Wang DD; Lin PP; Shen L
    Oncotarget; 2014 Aug; 5(16):6594-602. PubMed ID: 25026283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of analytic performances of Cellsearch and iFISH approach in detecting circulating tumor cells.
    Sheng Y; Wang T; Li H; Zhang Z; Chen J; He C; Li Y; Lv Y; Zhang J; Xu C; Wang Z; Huang C; Wang L
    Oncotarget; 2017 Jan; 8(5):8801-8806. PubMed ID: 28187533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma.
    Zhang J; Shi H; Jiang T; Liu Z; Lin PP; Chen N
    BMC Cancer; 2018 Nov; 18(1):1133. PubMed ID: 30454007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A Rare Case of Extremely High Counts of EpCAM
    Jiang TT; Li HP; Li YC
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 53(4):711-715. PubMed ID: 35871746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
    Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C
    Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients.
    Liu Z; Fusi A; Klopocki E; Schmittel A; Tinhofer I; Nonnenmacher A; Keilholz U
    J Transl Med; 2011 May; 9():70. PubMed ID: 21595914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
    Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
    Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization.
    Gao Y; Zhu Y; Zhang Z; Zhang C; Huang X; Yuan Z
    J Exp Clin Cancer Res; 2016 Apr; 35():66. PubMed ID: 27066900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of detecting circulating tumor cells in colorectal cancer using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH).
    Wu W; Zhang Z; Gao XH; Shen Z; Jing Y; Lu H; Li H; Yang X; Cui X; Li Y; Lou Z; Liu P; Zhang C; Zhang W
    Oncotarget; 2017 Mar; 8(13):21639-21649. PubMed ID: 28423493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low.
    Ring A; Mineyev N; Zhu W; Park E; Lomas C; Punj V; Yu M; Barrak D; Forte V; Porras T; Tripathy D; Lang JE
    Oncotarget; 2015 Dec; 6(42):44623-34. PubMed ID: 26556851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aneuploid CTC and CEC.
    Lin PP
    Diagnostics (Basel); 2018 Apr; 8(2):. PubMed ID: 29670052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer.
    Xu Y; Qin T; Li J; Wang X; Gao C; Xu C; Hao J; Liu J; Gao S; Ren H
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28333072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.